Results 251 to 260 of about 2,579,690 (304)
Extracellular vesicles derived from edible plants and edible fungi: Compositional characteristics, engineering strategies and biofunctions
Food Biomacromolecules, EarlyView.Non‐animal extracellular vesicles as bioactive‐compound carriers: compositional characteristics, engineering strategies, and biofunctions. Abstract
Animal‐derived extracellular vesicles (EVs) were widely used for bioactive compound delivery but constrained by complex origins, potential immunogenicity, and pathogen contamination.Jiahao Yu, Rongheng Chen, Yuxuan Liu, Yizhen Xie, Fangyu Fan, Simin Feng, Ping Shao +6 morewiley +1 more sourceGLUT1 expression, lymphocyte distribution and CD3<sup>+</sup> T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma. [PDF]
J Exp Clin Cancer ResPaver EC, Gide TN, Yaseen Z, Cornejo-Paramo P, Ferguson P, Maher NG, Menzies AM, Carlino MS, da Silva IP, Holst J, Long GV, Scolyer RA, Wilmott JS. +12 moreeuropepmc +1 more sourceA Computed Tomography Radiomics Approach for Assessing the T Cell‐Inflamed Gene Expression Profile in Hepatocellular Carcinoma and Its Association With Immunotherapy Response
Health Care Science, EarlyView.The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).Mimi Tang, Kaiyu Sun, Dasheng Wu, Yujian Zou, Jian Zhou, Bin Li, Huanjing Hu, Zhenpeng Peng, Jifei Wang, Bingsheng Huang, Shi‐Ting Feng, Shuling Chen +11 morewiley +1 more sourceCraniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series
Head &Neck, EarlyView.ABSTRACT Background
Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods
Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base Michael J. C. Schachtel, Benedict J. Panizza, James J. Bowman, Catherine Barnett, Cristina Valero, Ian Ganly, Snehal G. Patel, Helena Levyn, Dauren Adilbay, Alana Eagan, Marc A. Cohen, Lillian A. Boe, Junting Zheng, Mithat Gonen, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Luiz P. Kowalski, Ronaldo N. Toledo, Claudio Cernea, Sergio Goncalves, Dan M. Fliss, John R. de Almeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Alvaro Rivero Calle, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard J. Harvey, C. Rene Leemans, Jan‐Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ken Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Rodney J. Schlosser, Fernando L. Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna, Jatin P. Shah +52 morewiley +1 more sourceDelineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma. [PDF]
Genome MedKerr C, Soleimani S, Mulder DT, Nabbi A, Gray D, Pedersen S, Sotov V, Sudhaman S, Nguyen L, Hirano N, Ohashi PS, Butler MO, Pugh TJ. +12 moreeuropepmc +1 more sourceAntibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma. [PDF]
Curr OncolWang YS, Wang QY, Moise AE, Syed HC, Malo J, Soberano S, Belkaid W, Messaoudene M, Bélanger K, Desilets A, Jamal R, Routy B, Elkrief A. +12 moreeuropepmc +1 more sourceResponse rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. [PDF]
Clin Transl OncolEspinosa E, Berciano-Guerrero MÁ, Muñoz-Couselo E, Puértolas T, Manzano JL, Soria A, de Miguel PA, Crespo G, Sanz LG, Cerezuela-Fuentes P, de la Rosa CA, Majem M, Castaño AG, Berrocal A, Arroyo FRG, de la Borbolla MR, Bellido L, Martínez JM, Fernández LA, Carnicero AM, Castro RL, Rodríguez AB, Lecumberri MJ, Guzmán JCV, Balea BC, Rodríguez JF, Bautista JV, Pérez VN, Mujika K, Subias MC, Hernández B, Algarra SM, Márquez-Rodas I. +32 moreeuropepmc +1 more sourceLate-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. [PDF]
Cancers (Basel)Pozas J, Cheruvu S, Jaganathan PP, Ganesan P, Modi A, Larkin J, Cossar L, Olsson-Brown A, Johnson A, Garbutt N, Lee R, Jones J, Macklin-Doherty A, Young K, Latent Study Investigators. +14 moreeuropepmc +1 more source